Clinical study of bisphosphonates for bone metastasis in breast cancer
Yamada, K.; Kohno, N.
Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 9): 352-355
2007
ISSN/ISBN: 0047-1852 PMID: 18161130 Document Number: 607069
Document emailed within 1 workday
Related Documents
Dibekoglu, C.; Turanli, S.; Karaman, N.; Ozcelik, K.C.; Erdogan, O. 2015: Bone fracture in breast cancer patients with isolated bone metastasis Chirurgia 110(1): 43-48Yamashita, K.; Koyama, H.; Inaji, H. 1995: Prognostic significance of bone metastasis from breast cancer Clinical Orthopaedics and Related Research 312: 89-94
Saeki, T.; Ookubo, K.; Takeuchi, H.; Fujiuchi, N. 2006: The incidence and management of bone metastasis from breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(8): 1054-1057
Kocoglu, H.; Tural, D. 2016: About the article "Hepatic steatosis is associated with higher incidence of liver metastasis in patients with metastatic breast cancer; an observational clinical study" by Duran et al Journal of BUON: Official Journal of the Balkan Union of Oncology 21(1): 284
Vincent-Joyeux, F.; Bontoux, D.; Alcalay, M.; Daban, A.; Vincent, D. 1982: Bone metastasis of breast cancer. Apropos of a series of 50 cases La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 58(48): 2827-2831
Yoneda, T. 2011: Involvement of RANKL/RANK pathway in bone metastasis in breast cancer Clinical Calcium 21(8): 1159-1166
Iguchi, H.; Tanaka, S.; Ozawa, Y.; Kashiwakuma, T.; Kimura, T.; Hiraga, T.; Ozawa, H.; Kono, A. 1996: An experimental model of bone metastasis by human lung cancer cells: the role of parathyroid hormone-related protein in bone metastasis Cancer Research 56(17): 4040-4043
Vehmanen, L.; Saarto, T. 2010: Bisphosphonates and breast cancer Duodecim; Laaketieteellinen Aikakauskirja 126(10): 1229-1237
Cheng, C.; Komljenovic, D.; Pan, L.; Dimitrakopoulou-Strauss, A.; Strauss, L.; Bäuerle, T. 2011: Evaluation of treatment response of cilengitide in an experimental model of breast cancer bone metastasis using dynamic PET with 18F-FDG Hellenic Journal of Nuclear Medicine 14(1): 15-20
Muñiz-Díaz, E.; Ayats, R.; Soler, J.; Bordes, R.; López López, J.J.; Pujol-Moix, N. 1985: Metastasis of breast cancer and secondary acute myeloblastic leukosis. Simultaneous bone marrow infiltration Medicina Clinica 84(5): 195-198
Wada, N.; Ishii, S.; Ikeda, T.; Enomoto, K.; Kitajima, M. 1999: Serum tartrate resistant acid phosphatase as a potential marker of bone metastasis from breast cancer Anticancer Research 19(5c): 4515-4521
Kanda, K.; Waki, S.; Uchimura, M.; Kida, H.; Narita, K.; Harada, N. 1990: A case of bone and lung metastasis of breast cancer successfully treated with radiotherapy, chemotherapy and endocrine therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(12): 2421-2424
Taguchi, T.; Koyama, H.; Yayoi, K.; Wada, T.; Takatsuka, Y.; Sonoo, H.; Morimoto, K.; Tominaga, T.; Abe, R.; Enomoto, K. 1995: Long-term clinical study on TAP-144-SR, an LH-RH agonist depot formulation, in premenopausal patients with advanced or recurrent breast cancer. TAP-144-SR Breast Cancer Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(4): 495-508
Jiang, J.; Xia, M.; Feng, J.-B.; Kong, B.-H. 2007: Inhibitory effect of breast cancer metastasis suppressor l gene on metastasis of human ovarian cancer cell in vitro and in vivo Zhonghua Fu Chan Ke Za Zhi 42(6): 398-402
Aft, R. 2011: Bisphosphonates in breast cancer: antitumor effects Clinical Advances in Hematology and Oncology: H&o 9(4): 292-299
Barginear, M.F.; Van Poznak, C. 2010: Bisphosphonates: do we know their role in adjuvant breast cancer treatment? Oncology 24(6): 475; 478, 480
Iba, T.; Kidokoro, A.; Fukunaga, M.; Sugiyama, K.; Aihara, N.; Suda, M. 2001: The efficacy of combination chemotherapy of 5'-deoxy-5-fluorouridine (5'-DFUR), cyclophosphamide (CPA) and medroxyprogesterone acetate (MPA) for bone metastasis in breast cancer patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(7): 973-977
Mbalaviele, G.; Dunstan, C.R.; Sasaki, A.; Williams, P.J.; Mundy, G.R.; Yoneda, T. 1996: E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model Cancer Research 56(17): 4063-4070
Taguchi, T. 2018: Bone and calcium metabolism associated with malignancy. Clinical Characteristics and Treatment of Cancer Treatment Induced Bone Loss(CTIBL)in Breast Cancer Clinical Calcium 28(11): 1515-1517
Saad, F.; Chi, K.; Fleshner, N. 2004: The role of bisphosphonates in the management of bone metastases in prostate cancer Canadian Journal of Urology 11(5): 2376-2382